Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients

Author： Alffenaar Jan-Willem C.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.8, 2010-08, pp. : 559-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis

By  

Current Clinical Pharmacology, Vol. 5, Iss. 2, 2010-05 ,pp. : 96-114

Bentham Science Publishers

Access to resources Recommend Favorite

Factors Associated with Multidrug-resistant Tuberculosis: Comparison of Patients Born Inside and Outside of the Czech Republic

By Bartu V   Kopecka E   Havelkova M  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1156-1163

Field House Publishing

Access to resources Recommend Favorite

Treatment and Prevention of Multidrug-Resistant Tuberculosis

By Bastian I.   Colebunders R.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 633-661

Adis International

Access to resources Recommend Favorite

Linezolid was effective in the treatment of a case of multidrug-resistant tuberculotic spondylitis

By  

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis

By Kumar Gaurav   Sharma Sadhna   Shafiq Nusrat   Pandhi Promila   Khuller Gopal Krishan   Malhotra Samir  

Drug Delivery, Vol. 18, Iss. 1, 2011-01 ,pp. : 65-73

Informa Healthcare

Access to resources Recommend Favorite